(Q38372154)

2 September 2017

title

Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study (English)

1 reference

2 September 2017

1 reference

1 reference

P Horák

5

0 references

Dana Tegzova

D Tegzova

12

0 references

Jakub Závada

J Zavada

1

0 references

Marta Olejárová

M Olejarova

4

0 references

Romana Ryšavá

R Rysava

3

0 references

Vladimír Tesař

17

V Tesar

1 reference

2 September 2017

0 references

Ss Pesickova

2

1 reference

2 September 2017

Z Hrncír

6

1 reference

2 September 2017

I Rychlík

7

1 reference

2 September 2017

M Havrda

8

1 reference

2 September 2017

J Vítova

9

1 reference

2 September 2017

J Lukác

10

1 reference

2 September 2017

J Rovensky

11

1 reference

2 September 2017

J Böhmova

13

1 reference

2 September 2017

J Zadrazil

14

1 reference

2 September 2017

J Hána

15

1 reference

2 September 2017

C Dostál

16

1 reference

2 September 2017

language of work or name

1 reference

6 July 2010

1 reference

2 September 2017

1 reference

2 September 2017

volume

19

1 reference

2 September 2017

issue

11

1 reference

2 September 2017

page(s)

1281-1289

1 reference

Treatment of Diffuse Proliferative Lupus Nephritis with Prednisone and Combined Prednisone and Cyclophosphamide

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203310371155

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310371155

Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310371155

Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310371155

Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310371155

Cyclosporine-A plus steroids versus steroids alone in the 12-month treatment of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310371155

A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310371155

Effect of 1 year cyclosporine A treatment on the activity and renal involvement of systemic lupus erythematosus: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310371155

Ciclosporin in the treatment of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310371155

Long-term treatment of lupus nephritis with cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310371155

Clinical efficacy of cyclosporin a neoral in the treatment of paediatric lupus nephritis with heavy proteinuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310371155

Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310371155

Prognosis of Untreated Patients with Idiopathic Membranous Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310371155

A Randomized Pilot Trial Comparing Cyclosporine and Azathioprine for Maintenance Therapy in Diffuse Lupus Nephritis over Four Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310371155

21 January 2018

Identifiers

DOI

10.1177/0961203310371155

1 reference

2 September 2017

1 reference